Drug flibanserin-in hypoactive sexual desire disorder
Hypoactive sexual desire disorder (HSDD) is a widely known type of female sexual dysfunction that could also cause emotional distress and relationship problems. Flibanserin, a benzimidazole, was being studied as a treatment for premenopausal women with hypoactive sexual desire disorder because there...
Saved in:
Main Authors: | Pugazhenthan Thangaraju (Author), Hemasri Velmurugan (Author), Sree Sudha TY (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
by: Jayne CJ, et al.
Published: (2017) -
Hypoactive sexual desire disorder caused by antiepileptic drugs
by: M Singh, et al.
Published: (2015) -
Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study
by: Marianne J. Naguib, et al.
Published: (2021) -
Management of hypoactive sexual desire disorder in women in the gynecological setting
by: Lucia Alves da Silva Lara, et al.
Published: (2021) -
Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
by: Dennis A. Revicki, et al.
Published: (2020)